Companies in the genetics sector developing innovative solutions and technologies.
Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.
Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Euformatics offers high standard bioinformatics tools to interpret sequence data. Our one single test can provide all the cancer-relevant
Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity.
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
L7 Informatics provides a unified platform, L7|ESP®, that contextualizes data and eliminates business silos via process orchestration.
OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.
BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.
Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.
BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology.
Fortuna is a biotechnology company that provides forecasting and screening technology solutions for non-invasive embryo trait assessment.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Sania Therapeutics is developing safe and effective gene therapies for the nervous system
Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.
Acrigen Biosciences is dedicated to making gene editing safe.
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
A comprehensive platform and product suite for advanced therapeutics.
MicroByre is a biotechnology company that specializes in microbiology, synthetic biology, molecular biology, and machine learning..
Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked